Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2025-04-04 00:00:00 ET · period of report 2025-04-03 · accession 0001104659-25-031991 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-04-04 | 2025-04-03 | APRE | Gilad Oren | Pres, CEO, Dir | P - Purchase | $1.84 | +5,500 | 343.1K | +2% | +$10.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-03 | P | A | 2,497 | $1.80 | 345,620 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-03 | P | A | 3,003 | $1.87 | 343,123 | D | — | — |